Skip to content

What is Doege-Potter Syndrome in Solitary Fibrous Tumor?

Published: | Updated:

Doege-Potter Syndrome is a rare condition where a solitary fibrous tumor produces an insulin-like hormone called IGF-II. This abnormal hormone causes unexpected and dangerous drops in blood sugar (hypoglycemia). Surgically removing the tumor usually cures the low blood sugar immediately.

Key Takeaways

  • Doege-Potter Syndrome occurs when a solitary fibrous tumor produces an abnormal hormone that mimics insulin.
  • This hormone causes severe, unexpected drops in blood sugar, known as hypoglycemia.
  • Surgical removal of the tumor is the most effective treatment and typically resolves the blood sugar issues immediately.
  • If surgery is delayed, the condition can be managed with continuous glucose monitoring, specific medications, and fast-acting carbohydrates.

Yes, in some cases, a solitary fibrous tumor (SFT) can cause your blood sugar to drop dangerously low. This rare condition is known as Doege-Potter Syndrome. It happens when the tumor produces a hormone that mimics insulin, confusing your body’s blood sugar regulation. While these sudden drops can be frightening and dangerous, removing the tumor typically resolves the low blood sugar immediately.

What is Doege-Potter Syndrome?

Doege-Potter Syndrome is a type of paraneoplastic syndrome—a set of symptoms caused by a tumor’s abnormal chemical secretions rather than its physical growth [1].

In Doege-Potter Syndrome, the SFT produces an abnormal, oversized version of a hormone called Insulin-like Growth Factor-II (IGF-II), sometimes referred to as “big IGF-II” [1][2]. Normally, insulin is the main hormone responsible for lowering your blood sugar by helping cells absorb glucose (sugar) from your bloodstream. However, “big IGF-II” is so similar to insulin that it binds directly to your body’s insulin receptors [3].

This causes two major disruptions in your body:

  1. Excessive glucose uptake: Your muscles and tissues rapidly absorb sugar from your blood, acting as if you had received a large, unexpected dose of insulin [1].
  2. Reduced glucose production: It signals your liver to stop producing and releasing its natural sugar reserves [4].

The result is severe, unexpected drops in blood sugar (hypoglycemia), even if you do not have diabetes and your body’s natural insulin levels are actually very low [5].

Recognizing the Symptoms

Because the low blood sugar is driven by the tumor’s constant hormone production, episodes of hypoglycemia can happen at any time. However, they are often most noticeable after periods of fasting, such as first thing in the morning, or following physical exertion.

Symptoms of severe low blood sugar can include:

  • Intense sweating and chills
  • Dizziness, confusion, or difficulty concentrating
  • A rapid heartbeat or feeling jittery
  • Extreme fatigue or weakness
  • In severe cases, fainting, seizures, or loss of consciousness

Immediate Action During an Episode

If you suspect your blood sugar is crashing, standard medical first-aid prioritizes immediate safety over getting to a doctor right away. The common approach is the “15-15 rule,” which involves consuming 15 grams of fast-acting carbohydrates—such as half a cup of fruit juice, regular soda, or glucose tablets—and checking symptoms again after 15 minutes. Treating the low blood sugar safely at home is critical before you attempt to drive or travel to a clinic.

To officially confirm Doege-Potter Syndrome, your care team will eventually need blood tests drawn during an episode of low blood sugar to measure your glucose, insulin, and IGF-II levels [3][6]. Because episodes often happen unpredictably at home, doctors frequently prescribe a Continuous Glucose Monitor (CGM) or a standard finger-prick meter to track levels, or they may advise going to an Emergency Department safely to capture the necessary lab work while symptoms are active.

Treatment and Resolution

The most effective and curative treatment for Doege-Potter Syndrome is the surgical removal of the solitary fibrous tumor [7]. Once the tumor is removed, the source of the abnormal IGF-II is eliminated. For most patients, normal blood sugar regulation is restored almost immediately after the surgery [8][9].

If the tumor cannot be removed right away, or if it is too advanced for surgery, your medical team will help you manage the hypoglycemia to keep you safe. Management strategies may include:

  • Medical therapies: Medications like glucocorticoids (steroids) can help raise blood sugar levels and counteract the effects of the IGF-II hormone [10][11].
  • Dietary management: Eating frequent meals or taking complex carbohydrates like uncooked cornstarch before bed can provide a slow, steady release of sugar through the night [12]. Keep fast-acting carbohydrates on your nightstand for emergencies.
  • Tumor-directed therapies: Treatments designed to shrink the tumor or cut off its blood supply, such as embolization, can reduce the overall amount of IGF-II the tumor is able to produce [13].

Finally, many patients find it helpful to wear a medical alert bracelet. This ensures that if you lose consciousness, emergency responders immediately know to check and treat your blood sugar. Even after successful surgery, long-term follow-up is important. If the solitary fibrous tumor ever returns, recurrent blood sugar drops can serve as an early warning sign [14][15].

Frequently Asked Questions

What causes low blood sugar in solitary fibrous tumor patients?
In rare cases, a solitary fibrous tumor can produce an abnormal hormone called IGF-II that mimics insulin. This tricks your body into rapidly absorbing sugar from your blood, leading to severe and sudden drops in blood sugar.
How is Doege-Potter Syndrome treated?
The primary and most effective treatment is the surgical removal of the solitary fibrous tumor. Once the tumor is removed, it stops producing the abnormal hormone, and your blood sugar usually returns to normal immediately.
What should I do if my blood sugar drops suddenly at home?
Standard medical first-aid recommends the 15-15 rule: consume 15 grams of fast-acting carbohydrates, like fruit juice or glucose tablets, and recheck your symptoms after 15 minutes. It is critical to treat the low blood sugar safely at home before attempting to travel to a clinic.
How can I track my blood sugar levels before surgery?
Because episodes can be unpredictable, doctors frequently prescribe a Continuous Glucose Monitor (CGM) or a standard finger-prick meter. This allows you to safely track your blood sugar levels at home while you and your care team plan for surgery.
Should I see an endocrinologist for Doege-Potter Syndrome?
Adding an endocrinologist to your care team is highly recommended. An endocrinologist specializes in hormones and can help safely manage your blood sugar levels using medications or dietary strategies before, during, and after your tumor surgery.

Questions for Your Doctor

  • Should I be prescribed a Continuous Glucose Monitor (CGM) or a finger-prick meter to safely track my blood sugar at home while we plan for surgery?
  • If I have a severe low blood sugar episode at home, what specific protocol do you want me to follow, and who should I call after hours?
  • Should an endocrinologist be added to my care team to help manage my blood sugar before and during surgery?
  • Does the presence of Doege-Potter syndrome change the timing, urgency, or surgical approach for removing my tumor?

Questions for You

  • Have I recently felt confused, dizzy, or exceptionally sweaty, particularly in the mornings or after a long period without eating?
  • Are there people in my household who know how to recognize the signs of severe low blood sugar and help me if I become confused or lose consciousness?
  • Do I have easy access to fast-acting carbohydrates, like juice or glucose tablets, near my bed or where I spend the most time?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

References

  1. 1

    Doege-Potter syndrome in a patient with a giant abdominal solitary fibrous tumor: a case report and review of the literature.

    Rötgens J, Lapauw B, T'Sjoen G

    Acta clinica Belgica 2023; (78(4)):358-364 doi:10.1080/17843286.2023.2165652.

    PMID: 36641633
  2. 2

    Non-islet cell tumor hypoglycemia caused by intrathoracic solitary fibrous tumor: a case report.

    Kitada M, Yasuda S, Takahashi N, et al.

    Journal of cardiothoracic surgery 2016; (11()):49 doi:10.1186/s13019-016-0463-6.

    PMID: 27061182
  3. 3

    Non-islet cell tumor-induced hypoglycemia in the setting of metastatic intracranial hemangiopericytoma: case report and review of the literature.

    Nussbaum LA, Walton RM, Nussbaum ES

    British journal of neurosurgery 2023; (37(4)):829-831 doi:10.1080/02688697.2019.1671953.

    PMID: 31599173
  4. 4

    Imbalanced Expression of IGF2 and PCSK4 Is Associated With Overproduction of Big IGF2 in SFT With NICTH: A Pilot Study.

    Kawai S, Ariyasu H, Uraki S, et al.

    The Journal of clinical endocrinology and metabolism 2018; (103(7)):2728-2734 doi:10.1210/jc.2018-00593.

    PMID: 29897468
  5. 5

    A Case Report of Doege-Potter Syndrome: A Rare Cause of Hypoglycemia in a Patient without Diabetes.

    Corsano C, Paradiso M, Laudadio ED, et al.

    Journal of clinical medicine 2023; (12(12)) doi:10.3390/jcm12123984.

    PMID: 37373678
  6. 6

    Quantitative analysis of the concentrations of IGFs and several IGF-binding proteins in a large fibrous abdominal tumor and the circulation of a patient with hypoglycemia.

    van Doorn J, van de Hoef W, Dullaart RP

    BioFactors (Oxford, England) 2015; (41(3)):183-9 doi:10.1002/biof.1212.

    PMID: 26073062
  7. 7

    Doege-Potter Syndrome with a Benign Solitary Fibrous Tumor: A Case Report and Literature Review.

    Mohammed T, Ozcan G, Siddique AS, et al.

    Case reports in oncology 2021; (14(1)):470-476 doi:10.1159/000512823.

    PMID: 33976622
  8. 8

    Resolution of Refractory Nonislet Cell Tumor Hypoglycemia Following Resection of an Abdominal Solitary Fibrous Tumor.

    Horowitz M, Kurt S, Lanjewar S, et al.

    AACE endocrinology and diabetes 2026; (13(1)):41-45 doi:10.1016/j.aed.2025.09.001.

    PMID: 41641310
  9. 9

    Doege-Potter syndrome due to a solitary fibrous tumor of the pleura: a case report.

    Estrada-Maya J, Montejo JS, Báez López KD, Garzón JC

    Journal of medical case reports 2024; (18(1)):383 doi:10.1186/s13256-024-04658-1.

    PMID: 39138498
  10. 10

    Doege-Potter syndrome associated to metastatic solitary fibrous tumor.

    Andrade MO, de Sousa NDC, do Amaral PS, et al.

    Autopsy & case reports 2022; (12()):e2021412 doi:10.4322/acr.2021.412.

    PMID: 36569984
  11. 11

    A giant pelvic solitary fibrous tumor with Doege-Potter syndrome successfully treated with transcatheter arterial embolization followed by surgical resection: a case report.

    Yuza K, Sakata J, Nagaro H, et al.

    Surgical case reports 2020; (6(1)):299 doi:10.1186/s40792-020-01076-5.

    PMID: 33237401
  12. 12

    Successful Multimodal Treatment of an IGF2-Producing Solitary Fibrous Tumor With Acromegaloid Changes and Hypoglycemia.

    De Los Santos-Aguilar RG, Chávez-Villa M, Contreras AG, et al.

    Journal of the Endocrine Society 2019; (3(3)):537-543 doi:10.1210/js.2018-00281.

    PMID: 30788455
  13. 13

    Imatinib use in the management of a patient with Doege-Potter syndrome.

    Paz-Ibarra J, Lu-Antara J, Uscamayta BE, et al.

    Endocrinology, diabetes & metabolism case reports 2023; (2023(2)).

    PMID: 37931416
  14. 14

    Successful Surgical Treatment of a Recurrent Pelvic Solitary Fibrous Tumor of Uterine Origin Accompanied by Doege-Potter Syndrome: A Case Report.

    Deguchi Y, Komuta W, Watanabe T, et al.

    The American journal of case reports 2022; (23()):e936806 doi:10.12659/AJCR.936806.

    PMID: 36227783
  15. 15

    Recurrence of solitary fibrous tumor of the pleura with hypoglycemia (Doege-Potter Syndrome): a case report description.

    Wang C, Cao T, Hu G, et al.

    Frontiers in oncology 2023; (13()):1245289 doi:10.3389/fonc.2023.1245289.

    PMID: 37823058

This information about Doege-Potter Syndrome and blood sugar management is for educational purposes only. Always consult your oncologist and endocrinologist for medical advice and emergency hypoglycemia protocols.

Stay up to date

Get notified when new research about Solitary Fibrous Tumor (SFT) is published.

No spam. Unsubscribe anytime.